Search Results
Adam W Nelson
Adam W Nelson
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Search for other papers by Adam W Nelson in
Google Scholar
PubMed
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Search for other papers by Adam W Nelson in
Google Scholar
PubMed
Wayne D Tilley
Wayne D Tilley
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Search for other papers by Wayne D Tilley in
Google Scholar
PubMed
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Search for other papers by Wayne D Tilley in
Google Scholar
PubMed
David E Neal
David E Neal
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Search for other papers by David E Neal in
Google Scholar
PubMed
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Search for other papers by David E Neal in
Google Scholar
PubMed
Jason S Carroll
Jason S Carroll
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Search for other papers by Jason S Carroll in
Google Scholar
PubMed
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Search for other papers by Jason S Carroll in
Google Scholar
PubMed
Introduction Prostate cancer is the commonest, non-cutaneous cancer in men, affecting 214 per 1000 European men. It is the second commonest cause of cancer death, accounting for 15% of all male cancers in developed countries ( Heidenreich et al
Matias Knuuttila
Matias Knuuttila
Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland
Turku Center for Disease Modeling (TCDM), Institute of Biomedicine, University of Turku, Turku, Finland
Search for other papers by Matias Knuuttila in
Google Scholar
PubMed
Turku Center for Disease Modeling (TCDM), Institute of Biomedicine, University of Turku, Turku, Finland
Search for other papers by Matias Knuuttila in
Google Scholar
PubMed
Arfa Mehmood
Arfa Mehmood
Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland
Search for other papers by Arfa Mehmood in
Google Scholar
PubMed
Search for other papers by Arfa Mehmood in
Google Scholar
PubMed
Jenni Mäki-Jouppila
Jenni Mäki-Jouppila
Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland
Turku Center for Disease Modeling (TCDM), Institute of Biomedicine, University of Turku, Turku, Finland
Search for other papers by Jenni Mäki-Jouppila in
Google Scholar
PubMed
Turku Center for Disease Modeling (TCDM), Institute of Biomedicine, University of Turku, Turku, Finland
Search for other papers by Jenni Mäki-Jouppila in
Google Scholar
PubMed
Henrik Ryberg
Henrik Ryberg
Center for Bone and Arthitis Research, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Henrik Ryberg in
Google Scholar
PubMed
Search for other papers by Henrik Ryberg in
Google Scholar
PubMed
Pekka Taimen
Pekka Taimen
Department of Pathology, University of Turku and Turku University Hospital, Turku, Finland
Search for other papers by Pekka Taimen in
Google Scholar
PubMed
Search for other papers by Pekka Taimen in
Google Scholar
PubMed
Juha Knaapila
Juha Knaapila
Department of Urology, Turku University Hospital, Turku, Finland
Search for other papers by Juha Knaapila in
Google Scholar
PubMed
Search for other papers by Juha Knaapila in
Google Scholar
PubMed
Otto Ettala
Otto Ettala
Department of Urology, Turku University Hospital, Turku, Finland
Search for other papers by Otto Ettala in
Google Scholar
PubMed
Search for other papers by Otto Ettala in
Google Scholar
PubMed
Peter J Boström
Peter J Boström
Department of Urology, Turku University Hospital, Turku, Finland
Search for other papers by Peter J Boström in
Google Scholar
PubMed
Search for other papers by Peter J Boström in
Google Scholar
PubMed
Claes Ohlsson
Claes Ohlsson
Center for Bone and Arthitis Research, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Claes Ohlsson in
Google Scholar
PubMed
Search for other papers by Claes Ohlsson in
Google Scholar
PubMed
Mikko S Venäläinen
Mikko S Venäläinen
Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland
Search for other papers by Mikko S Venäläinen in
Google Scholar
PubMed
Search for other papers by Mikko S Venäläinen in
Google Scholar
PubMed
Asta Laiho
Asta Laiho
Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland
Search for other papers by Asta Laiho in
Google Scholar
PubMed
Search for other papers by Asta Laiho in
Google Scholar
PubMed
Laura L Elo
Laura L Elo
Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland
Search for other papers by Laura L Elo in
Google Scholar
PubMed
Search for other papers by Laura L Elo in
Google Scholar
PubMed
Petra Sipilä
Petra Sipilä
Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland
Turku Center for Disease Modeling (TCDM), Institute of Biomedicine, University of Turku, Turku, Finland
Search for other papers by Petra Sipilä in
Google Scholar
PubMed
Turku Center for Disease Modeling (TCDM), Institute of Biomedicine, University of Turku, Turku, Finland
Search for other papers by Petra Sipilä in
Google Scholar
PubMed
Sari I Mäkelä
Sari I Mäkelä
Turku Center for Disease Modeling (TCDM), Institute of Biomedicine, University of Turku, Turku, Finland
Functional Foods Forum, University of Turku, Turku, Finland
Search for other papers by Sari I Mäkelä in
Google Scholar
PubMed
Functional Foods Forum, University of Turku, Turku, Finland
Search for other papers by Sari I Mäkelä in
Google Scholar
PubMed
Matti Poutanen
Matti Poutanen
Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland
Turku Center for Disease Modeling (TCDM), Institute of Biomedicine, University of Turku, Turku, Finland
Center for Bone and Arthitis Research, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Matti Poutanen in
Google Scholar
PubMed
Turku Center for Disease Modeling (TCDM), Institute of Biomedicine, University of Turku, Turku, Finland
Center for Bone and Arthitis Research, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Matti Poutanen in
Google Scholar
PubMed
Introduction Androgens play a crucial role in the normal development and growth of the prostate and the growth of prostate cancer. The prostate tissue is known for the local biosynthesis of dihydrotestosterone (DHT), which is the principal
Joanna M Day
Joanna M Day
Search for other papers by Joanna M Day in
Google Scholar
PubMed
Search for other papers by Joanna M Day in
Google Scholar
PubMed
Paul A Foster
Paul A Foster
Oncology Drug Discovery and Women's Health Group, School of Clinical and Experimental Medicine, IPSEN, Medicinal Chemistry, Division of Diabetes, Endocrinology and Metabolism, and Sterix Ltd., Imperial College London, London W12 0NN, UK
Search for other papers by Paul A Foster in
Google Scholar
PubMed
Search for other papers by Paul A Foster in
Google Scholar
PubMed
Helena J Tutill
Helena J Tutill
Search for other papers by Helena J Tutill in
Google Scholar
PubMed
Search for other papers by Helena J Tutill in
Google Scholar
PubMed
Fabien Schmidlin
Fabien Schmidlin
Oncology Drug Discovery and Women's Health Group, School of Clinical and Experimental Medicine, IPSEN, Medicinal Chemistry, Division of Diabetes, Endocrinology and Metabolism, and Sterix Ltd., Imperial College London, London W12 0NN, UK
Search for other papers by Fabien Schmidlin in
Google Scholar
PubMed
Search for other papers by Fabien Schmidlin in
Google Scholar
PubMed
Christopher M Sharland
Christopher M Sharland
Oncology Drug Discovery and Women's Health Group, School of Clinical and Experimental Medicine, IPSEN, Medicinal Chemistry, Division of Diabetes, Endocrinology and Metabolism, and Sterix Ltd., Imperial College London, London W12 0NN, UK
Search for other papers by Christopher M Sharland in
Google Scholar
PubMed
Search for other papers by Christopher M Sharland in
Google Scholar
PubMed
Jonathan D Hargrave
Jonathan D Hargrave
Oncology Drug Discovery and Women's Health Group, School of Clinical and Experimental Medicine, IPSEN, Medicinal Chemistry, Division of Diabetes, Endocrinology and Metabolism, and Sterix Ltd., Imperial College London, London W12 0NN, UK
Search for other papers by Jonathan D Hargrave in
Google Scholar
PubMed
Search for other papers by Jonathan D Hargrave in
Google Scholar
PubMed
Nigel Vicker
Nigel Vicker
Oncology Drug Discovery and Women's Health Group, School of Clinical and Experimental Medicine, IPSEN, Medicinal Chemistry, Division of Diabetes, Endocrinology and Metabolism, and Sterix Ltd., Imperial College London, London W12 0NN, UK
Search for other papers by Nigel Vicker in
Google Scholar
PubMed
Search for other papers by Nigel Vicker in
Google Scholar
PubMed
Barry V L Potter
Barry V L Potter
Oncology Drug Discovery and Women's Health Group, School of Clinical and Experimental Medicine, IPSEN, Medicinal Chemistry, Division of Diabetes, Endocrinology and Metabolism, and Sterix Ltd., Imperial College London, London W12 0NN, UK
Search for other papers by Barry V L Potter in
Google Scholar
PubMed
Search for other papers by Barry V L Potter in
Google Scholar
PubMed
Michael J Reed
Michael J Reed
Search for other papers by Michael J Reed in
Google Scholar
PubMed
Search for other papers by Michael J Reed in
Google Scholar
PubMed
Atul Purohit
Atul Purohit
Search for other papers by Atul Purohit in
Google Scholar
PubMed
Search for other papers by Atul Purohit in
Google Scholar
PubMed
Introduction Treatment of hormone-dependent prostate cancer by androgen ablation is usually initially successful, reducing primary tumour burden and increasing 5-year survival rates. Currently, androgen ablation is achieved using orchidectomy
Luke A Selth
Luke A Selth
Dame Roma Mitchell Cancer Research Laboratories and Adelaide Prostate Cancer Research Centre, University of Adelaide and Hanson Institute, Adelaide 5000, Australia
Search for other papers by Luke A Selth in
Google Scholar
PubMed
Search for other papers by Luke A Selth in
Google Scholar
PubMed
Wayne D Tilley
Wayne D Tilley
Dame Roma Mitchell Cancer Research Laboratories and Adelaide Prostate Cancer Research Centre, University of Adelaide and Hanson Institute, Adelaide 5000, Australia
Search for other papers by Wayne D Tilley in
Google Scholar
PubMed
Search for other papers by Wayne D Tilley in
Google Scholar
PubMed
Lisa M Butler
Lisa M Butler
Dame Roma Mitchell Cancer Research Laboratories and Adelaide Prostate Cancer Research Centre, University of Adelaide and Hanson Institute, Adelaide 5000, Australia
Search for other papers by Lisa M Butler in
Google Scholar
PubMed
Search for other papers by Lisa M Butler in
Google Scholar
PubMed
in prostate cancer (PCa), thyroid cancer, neuroblastoma, and glioblastoma but acts as a tumor suppressor in ovarian and breast cancer (for review, see Cortez et al . (2011) ). Such dichotomy in respect to miRNA function in cancer is not uncommon and
T M Murphy
T M Murphy
Prostate Cancer Research Group, Institute of Molecular Medicine, Trinity College Dublin, Ireland
Search for other papers by T M Murphy in
Google Scholar
PubMed
Search for other papers by T M Murphy in
Google Scholar
PubMed
A S Perry
A S Perry
Prostate Cancer Research Group, Institute of Molecular Medicine, Trinity College Dublin, Ireland
Search for other papers by A S Perry in
Google Scholar
PubMed
Search for other papers by A S Perry in
Google Scholar
PubMed
M Lawler
M Lawler
Prostate Cancer Research Group, Institute of Molecular Medicine, Trinity College Dublin, Ireland
Search for other papers by M Lawler in
Google Scholar
PubMed
Search for other papers by M Lawler in
Google Scholar
PubMed
Introduction Prostate cancer represents a global public health problem. Worldwide, it is the second most common noncutaneous cancer in men, accounting for ∼10% of male cancers ( Parkin et al . 2005 ). Prostate cancer is the second leading cause of
Renea A Taylor
Renea A Taylor
Prostate and Breast Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria 3800, Australia
Search for other papers by Renea A Taylor in
Google Scholar
PubMed
Search for other papers by Renea A Taylor in
Google Scholar
PubMed
Roxanne Toivanen
Roxanne Toivanen
Prostate and Breast Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria 3800, Australia
Search for other papers by Roxanne Toivanen in
Google Scholar
PubMed
Search for other papers by Roxanne Toivanen in
Google Scholar
PubMed
Gail P Risbridger
Gail P Risbridger
Prostate and Breast Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria 3800, Australia
Search for other papers by Gail P Risbridger in
Google Scholar
PubMed
Search for other papers by Gail P Risbridger in
Google Scholar
PubMed
Introduction Prostate cancer is a major cause of morbidity and mortality in men around the world, being the most common solid tumor. In America, ∼6 out of every 50 men over the age of 50 will be diagnosed with prostate cancer in his lifetime. In
Suresh Veeramani
Suresh Veeramani
Search for other papers by Suresh Veeramani in
Google Scholar
PubMed
Search for other papers by Suresh Veeramani in
Google Scholar
PubMed
Ta-Chun Yuan
Ta-Chun Yuan
Search for other papers by Ta-Chun Yuan in
Google Scholar
PubMed
Search for other papers by Ta-Chun Yuan in
Google Scholar
PubMed
Siu-Ju Chen
Siu-Ju Chen
Search for other papers by Siu-Ju Chen in
Google Scholar
PubMed
Search for other papers by Siu-Ju Chen in
Google Scholar
PubMed
Fen-Fen Lin
Fen-Fen Lin
Search for other papers by Fen-Fen Lin in
Google Scholar
PubMed
Search for other papers by Fen-Fen Lin in
Google Scholar
PubMed
Juliette E Petersen
Juliette E Petersen
Search for other papers by Juliette E Petersen in
Google Scholar
PubMed
Search for other papers by Juliette E Petersen in
Google Scholar
PubMed
Syed Shaheduzzaman
Syed Shaheduzzaman
Search for other papers by Syed Shaheduzzaman in
Google Scholar
PubMed
Search for other papers by Syed Shaheduzzaman in
Google Scholar
PubMed
Shiv Srivastava
Shiv Srivastava
Search for other papers by Shiv Srivastava in
Google Scholar
PubMed
Search for other papers by Shiv Srivastava in
Google Scholar
PubMed
Richard G MacDonald
Richard G MacDonald
Search for other papers by Richard G MacDonald in
Google Scholar
PubMed
Search for other papers by Richard G MacDonald in
Google Scholar
PubMed
Ming-Fong Lin
Ming-Fong Lin
Search for other papers by Ming-Fong Lin in
Google Scholar
PubMed
Search for other papers by Ming-Fong Lin in
Google Scholar
PubMed
PAcP is a 100 kDa glycoprotein containing two subunits of approximately 50 kDa each. In the mid 1930s, Gutman and his colleagues made the noteworthy observation that the activity of PAcP is increased in the circulation of patients with prostate cancer
Amy A Lubik
Amy A Lubik
Institute of Health and Biomedical Innovation, Vancouver Prostate Centre, Departments of Medicine and Oncology, Australian Prostate Cancer Research Centre – Queensland, Princess Alexandra Hospital, Queensland University of Technology, Level 1, Building 1, 199 Ipswich Road, Brisbane, Queensland 4102, Australia
Institute of Health and Biomedical Innovation, Vancouver Prostate Centre, Departments of Medicine and Oncology, Australian Prostate Cancer Research Centre – Queensland, Princess Alexandra Hospital, Queensland University of Technology, Level 1, Building 1, 199 Ipswich Road, Brisbane, Queensland 4102, Australia
Search for other papers by Amy A Lubik in
Google Scholar
PubMed
Institute of Health and Biomedical Innovation, Vancouver Prostate Centre, Departments of Medicine and Oncology, Australian Prostate Cancer Research Centre – Queensland, Princess Alexandra Hospital, Queensland University of Technology, Level 1, Building 1, 199 Ipswich Road, Brisbane, Queensland 4102, Australia
Search for other papers by Amy A Lubik in
Google Scholar
PubMed
Jennifer H Gunter
Jennifer H Gunter
Institute of Health and Biomedical Innovation, Vancouver Prostate Centre, Departments of Medicine and Oncology, Australian Prostate Cancer Research Centre – Queensland, Princess Alexandra Hospital, Queensland University of Technology, Level 1, Building 1, 199 Ipswich Road, Brisbane, Queensland 4102, Australia
Search for other papers by Jennifer H Gunter in
Google Scholar
PubMed
Search for other papers by Jennifer H Gunter in
Google Scholar
PubMed
Brett G Hollier
Brett G Hollier
Institute of Health and Biomedical Innovation, Vancouver Prostate Centre, Departments of Medicine and Oncology, Australian Prostate Cancer Research Centre – Queensland, Princess Alexandra Hospital, Queensland University of Technology, Level 1, Building 1, 199 Ipswich Road, Brisbane, Queensland 4102, Australia
Search for other papers by Brett G Hollier in
Google Scholar
PubMed
Search for other papers by Brett G Hollier in
Google Scholar
PubMed
Susan Ettinger
Susan Ettinger
Institute of Health and Biomedical Innovation, Vancouver Prostate Centre, Departments of Medicine and Oncology, Australian Prostate Cancer Research Centre – Queensland, Princess Alexandra Hospital, Queensland University of Technology, Level 1, Building 1, 199 Ipswich Road, Brisbane, Queensland 4102, Australia
Search for other papers by Susan Ettinger in
Google Scholar
PubMed
Search for other papers by Susan Ettinger in
Google Scholar
PubMed
Ladan Fazli
Ladan Fazli
Institute of Health and Biomedical Innovation, Vancouver Prostate Centre, Departments of Medicine and Oncology, Australian Prostate Cancer Research Centre – Queensland, Princess Alexandra Hospital, Queensland University of Technology, Level 1, Building 1, 199 Ipswich Road, Brisbane, Queensland 4102, Australia
Search for other papers by Ladan Fazli in
Google Scholar
PubMed
Search for other papers by Ladan Fazli in
Google Scholar
PubMed
Nataly Stylianou
Nataly Stylianou
Institute of Health and Biomedical Innovation, Vancouver Prostate Centre, Departments of Medicine and Oncology, Australian Prostate Cancer Research Centre – Queensland, Princess Alexandra Hospital, Queensland University of Technology, Level 1, Building 1, 199 Ipswich Road, Brisbane, Queensland 4102, Australia
Search for other papers by Nataly Stylianou in
Google Scholar
PubMed
Search for other papers by Nataly Stylianou in
Google Scholar
PubMed
Stephen C Hendy
Stephen C Hendy
Institute of Health and Biomedical Innovation, Vancouver Prostate Centre, Departments of Medicine and Oncology, Australian Prostate Cancer Research Centre – Queensland, Princess Alexandra Hospital, Queensland University of Technology, Level 1, Building 1, 199 Ipswich Road, Brisbane, Queensland 4102, Australia
Search for other papers by Stephen C Hendy in
Google Scholar
PubMed
Search for other papers by Stephen C Hendy in
Google Scholar
PubMed
Hans H Adomat
Hans H Adomat
Institute of Health and Biomedical Innovation, Vancouver Prostate Centre, Departments of Medicine and Oncology, Australian Prostate Cancer Research Centre – Queensland, Princess Alexandra Hospital, Queensland University of Technology, Level 1, Building 1, 199 Ipswich Road, Brisbane, Queensland 4102, Australia
Search for other papers by Hans H Adomat in
Google Scholar
PubMed
Search for other papers by Hans H Adomat in
Google Scholar
PubMed
Martin E Gleave
Martin E Gleave
Institute of Health and Biomedical Innovation, Vancouver Prostate Centre, Departments of Medicine and Oncology, Australian Prostate Cancer Research Centre – Queensland, Princess Alexandra Hospital, Queensland University of Technology, Level 1, Building 1, 199 Ipswich Road, Brisbane, Queensland 4102, Australia
Search for other papers by Martin E Gleave in
Google Scholar
PubMed
Search for other papers by Martin E Gleave in
Google Scholar
PubMed
Michael Pollak
Michael Pollak
Institute of Health and Biomedical Innovation, Vancouver Prostate Centre, Departments of Medicine and Oncology, Australian Prostate Cancer Research Centre – Queensland, Princess Alexandra Hospital, Queensland University of Technology, Level 1, Building 1, 199 Ipswich Road, Brisbane, Queensland 4102, Australia
Search for other papers by Michael Pollak in
Google Scholar
PubMed
Search for other papers by Michael Pollak in
Google Scholar
PubMed
Adrian Herington
Adrian Herington
Institute of Health and Biomedical Innovation, Vancouver Prostate Centre, Departments of Medicine and Oncology, Australian Prostate Cancer Research Centre – Queensland, Princess Alexandra Hospital, Queensland University of Technology, Level 1, Building 1, 199 Ipswich Road, Brisbane, Queensland 4102, Australia
Search for other papers by Adrian Herington in
Google Scholar
PubMed
Search for other papers by Adrian Herington in
Google Scholar
PubMed
Colleen C Nelson
Colleen C Nelson
Institute of Health and Biomedical Innovation, Vancouver Prostate Centre, Departments of Medicine and Oncology, Australian Prostate Cancer Research Centre – Queensland, Princess Alexandra Hospital, Queensland University of Technology, Level 1, Building 1, 199 Ipswich Road, Brisbane, Queensland 4102, Australia
Institute of Health and Biomedical Innovation, Vancouver Prostate Centre, Departments of Medicine and Oncology, Australian Prostate Cancer Research Centre – Queensland, Princess Alexandra Hospital, Queensland University of Technology, Level 1, Building 1, 199 Ipswich Road, Brisbane, Queensland 4102, Australia
Search for other papers by Colleen C Nelson in
Google Scholar
PubMed
Institute of Health and Biomedical Innovation, Vancouver Prostate Centre, Departments of Medicine and Oncology, Australian Prostate Cancer Research Centre – Queensland, Princess Alexandra Hospital, Queensland University of Technology, Level 1, Building 1, 199 Ipswich Road, Brisbane, Queensland 4102, Australia
Search for other papers by Colleen C Nelson in
Google Scholar
PubMed
factors insulin and IGF1 have been implicated in prostate cancer (PC) progression ( Pollak 2008 a , Lubik et al . 2011 ); however, the role of IGF2 is less well explored. IGF2 expression is elevated in ovarian, colorectal and breast cancer associated
Marianna Volpert
Marianna Volpert
Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia
Search for other papers by Marianna Volpert in
Google Scholar
PubMed
Search for other papers by Marianna Volpert in
Google Scholar
PubMed
Luc Furic
Luc Furic
Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia
Prostate Cancer Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia
Cancer Program, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia
Search for other papers by Luc Furic in
Google Scholar
PubMed
Prostate Cancer Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia
Cancer Program, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia
Search for other papers by Luc Furic in
Google Scholar
PubMed
Jinghua Hu
Jinghua Hu
Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia
The School of Biological Sciences, Monash University, Clayton, Victoria, Australia
Search for other papers by Jinghua Hu in
Google Scholar
PubMed
The School of Biological Sciences, Monash University, Clayton, Victoria, Australia
Search for other papers by Jinghua Hu in
Google Scholar
PubMed
Anne E O’Connor
Anne E O’Connor
Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia
The School of Biological Sciences, Monash University, Clayton, Victoria, Australia
Search for other papers by Anne E O’Connor in
Google Scholar
PubMed
The School of Biological Sciences, Monash University, Clayton, Victoria, Australia
Search for other papers by Anne E O’Connor in
Google Scholar
PubMed
Richard J Rebello
Richard J Rebello
Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia
Search for other papers by Richard J Rebello in
Google Scholar
PubMed
Search for other papers by Richard J Rebello in
Google Scholar
PubMed
Shivakumar Keerthikumar
Shivakumar Keerthikumar
Prostate Cancer Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia
Computational Cancer Biology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Search for other papers by Shivakumar Keerthikumar in
Google Scholar
PubMed
Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia
Computational Cancer Biology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Search for other papers by Shivakumar Keerthikumar in
Google Scholar
PubMed
Jemma Evans
Jemma Evans
The Hudson Institute of Medical Research, Clayton, Victoria, Australia
Department of Physiology, Monash University, Clayton, Victoria, Australia
Search for other papers by Jemma Evans in
Google Scholar
PubMed
Department of Physiology, Monash University, Clayton, Victoria, Australia
Search for other papers by Jemma Evans in
Google Scholar
PubMed
D Jo Merriner
D Jo Merriner
Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia
The School of Biological Sciences, Monash University, Clayton, Victoria, Australia
Search for other papers by D Jo Merriner in
Google Scholar
PubMed
The School of Biological Sciences, Monash University, Clayton, Victoria, Australia
Search for other papers by D Jo Merriner in
Google Scholar
PubMed
John Pedersen
John Pedersen
Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia
Search for other papers by John Pedersen in
Google Scholar
PubMed
Search for other papers by John Pedersen in
Google Scholar
PubMed
Gail P Risbridger
Gail P Risbridger
Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia
Prostate Cancer Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia
Cancer Program, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia
Search for other papers by Gail P Risbridger in
Google Scholar
PubMed
Prostate Cancer Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia
Cancer Program, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia
Search for other papers by Gail P Risbridger in
Google Scholar
PubMed
Peter McIntyre
Peter McIntyre
Health Innovations Research Institute and School of Medical Sciences, RMIT University, Bundoora, Victoria, Australia.
Search for other papers by Peter McIntyre in
Google Scholar
PubMed
Search for other papers by Peter McIntyre in
Google Scholar
PubMed
Moira K O’Bryan
Moira K O’Bryan
Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia
The School of Biological Sciences, Monash University, Clayton, Victoria, Australia
Search for other papers by Moira K O’Bryan in
Google Scholar
PubMed
The School of Biological Sciences, Monash University, Clayton, Victoria, Australia
Search for other papers by Moira K O’Bryan in
Google Scholar
PubMed
Introduction Prostate cancer is the most common male cancer in Western societies and the third most common cause of cancer-related mortality ( Jemal et al. 2011 ). Localised prostate cancer is well managed clinically with a 5-year survival
Tanya K Day
Tanya K Day
Search for other papers by Tanya K Day in
Google Scholar
PubMed
Search for other papers by Tanya K Day in
Google Scholar
PubMed
Tina Bianco-Miotto
Tina Bianco-Miotto
Dame Roma Mitchell Cancer Research Laboratories, School of Paediatrics and Reproductive Health, School of Agriculture, Discipline of Medicine, Hanson Institute, Adelaide Prostate Cancer Research Centre, The University of Adelaide, Adelaide, South Australia, Australia
Dame Roma Mitchell Cancer Research Laboratories, School of Paediatrics and Reproductive Health, School of Agriculture, Discipline of Medicine, Hanson Institute, Adelaide Prostate Cancer Research Centre, The University of Adelaide, Adelaide, South Australia, Australia
Search for other papers by Tina Bianco-Miotto in
Google Scholar
PubMed
Dame Roma Mitchell Cancer Research Laboratories, School of Paediatrics and Reproductive Health, School of Agriculture, Discipline of Medicine, Hanson Institute, Adelaide Prostate Cancer Research Centre, The University of Adelaide, Adelaide, South Australia, Australia
Search for other papers by Tina Bianco-Miotto in
Google Scholar
PubMed
Introduction Numerous diseases are associated with abnormal hormonal regulation including breast and prostate cancers. Breast cancer is a heterogeneous disease that can be classified in many ways. The most primary classification is by hormone
